USA-based Praxis Precision Medicines, a biopharma translating genetic insights into the development of therapies for central ...

New York-based Immunai, a biotech that uses single-cell genomics and machine learning to discover and improve development of ...

Shares of China’s Hansoh Pharmaceutical edged up 2% to HK$36.50 as it announced a license agreement with Roche for HS-20110, ...

The European Medicine Agency’s (EMA) human medicines committee (CHMP) recommended two novel medicines for approval at its ...

Anglo-Swedish pharma major AstraZeneca (LSE: AZN) has presented new data showing the impact of its PD-L1 inhibitor Imfinzi ...

US hematology specialist Disc Medicine surged 19.7% in after-hours trading Thursday after the company announced it received a ...

Chinese biotech Kelun-Biotech (HKEX: 6990) has gained approval from the National Medical Products Administration for ...

US clinical-stage autoimmune diseases focused biotech Dianthus Therapeutics revealed it has entered into an exclusive ...

US-China biotech I-Mab (Nasdaq: IMAB) is planning a strategic overhaul that includes a new name, NovaBridge Biosciences, and ...

US pharma major Eli Lilly has announced results from the primary overall survival (OS) analysis of the Phase III monarchE ...

USA-based clinical-stage dermatology start-up Veradermics has announced the completion of an oversubscribed $150 million ...

The European Parliament’s rapporteur has recently presented draft reforms to the proposed EU Critical Medicines Act, ...